disprofas

cranv0.2.1

Non-Parametric Dissolution Profile Analysis. Similarity of dissolution profiles is assessed using the similarity factor f2 according to the EMA guideline (European Medicines Agency 2010) "On the investigation of bioequivalence". Dissolution profiles are regarded as similar if the f2 value is between 50 and 100. For the applicability of the sim

License GPL (>= 2)0 versions1 maintainers3 deps225 weekly dl
piusdahinden/disprofas
41
/ 100
Health
safe to use

[email protected] is safe to use (health: 41/100)

Health breakdown0 – 100
5/25
maintenance
3/20
popularity
25/25
security
6/15
maturity
2/15
community
Vulnerabilities
0
none known

Health History

Dependency Tree

License Audit

Dependencies (3)
API access

Get this data programmatically — free, no authentication.

curl https://depscope.dev/api/check/cran/disprofas

First published · 2025-03-24 02:18:55

Last updated · 2025-03-24T00:00:07+00:00